Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000472149 | SCV000563220 | likely benign | Chuvash polycythemia; Von Hippel-Lindau syndrome | 2023-12-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436520 | SCV002747403 | likely benign | Hereditary cancer-predisposing syndrome | 2021-04-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004002230 | SCV004841226 | likely benign | Von Hippel-Lindau syndrome | 2023-10-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV004584727 | SCV005075721 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | VHL: BP4, BP7 |